These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33794628)

  • 1. [Pathologic tumor volume predicting survival outcomes of patients with local advanced glottic carcinoma].
    Gong H; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Zhou J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Apr; 35(4):316-320. PubMed ID: 33794628
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic Tumor Size as a Predictor of the Survival Outcomes of Patients With Glottic Carcinoma.
    Gong H; Zhou L; Wu H; Tao L; Zhang M; Chen X; Li X; Li C; Zhou J; Wang S
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):353-358. PubMed ID: 32633609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of tumor volume in supraglottic and glottic laryngeal carcinoma.
    van Bockel LW; Monninkhof EM; Pameijer FA; Terhaard CH
    Strahlenther Onkol; 2013 Dec; 189(12):1009-14. PubMed ID: 24196282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative tracheotomy as reflection of tumor size impacting oncologic outcomes of patients with advanced stage glottic carcinoma.
    Gong H; Zhou L; Wu C; Hsueh CY; Tao L; Wu H; Zhang M; Chen X; Li C; Zhou J
    Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):4943-4950. PubMed ID: 33675419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.
    Zhou J; Zhu X; Yang Y; Zhou L; Gong H; Xu C; Tao L
    Acta Otolaryngol; 2023 Apr; 143(4):317-321. PubMed ID: 36994848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of pathological tumor size in patients with supraglottic carcinoma.
    Gong H; Zhou L; Hsueh CY; Wu H; Tao L; Zhang M; Chen X; Li C; Mo M; Zhou J
    Am J Otolaryngol; 2021; 42(1):102757. PubMed ID: 33128995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Primary Tumor Volume With Survival in Patients With T3 Glottic Cancer Treated With Radiotherapy: A Study of the Canadian Head & Neck Collaborative Research Initiative.
    Malik NH; Fu R; Hainc N; Noel CW; de Almeida JR; Hosni A; Hui Huang S; Yu E; Dzioba A; Leung A; Mangat A; MacNeil D; Nichols AC; Hiremath SB; Chakraborty S; Jooya A; Gaudet M; Johnson-Obaseki S; Whelan J; Forghani R; Hier MP; Morand G; Sultanem K; Dort J; Lysack J; Matthews W; Nakoneshny S; Gill G; Globerman A; Kerr P; Maralani P; Karam I; Eskander A
    JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):103-109. PubMed ID: 36480193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low expression of pRB predicts disease relapse in early glottic cancer treated with transoral laser microsurgery.
    Lee LA; Fang TJ; Li HY; Huang CG; Chen TC; Liao CT; Kang CJ; Chang KP; Yen TC
    Laryngoscope; 2019 Jun; 129(6):E220-E226. PubMed ID: 30382590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor volume as a prognostic factor of locally advanced laryngeal cancer.
    de Andrade NMM; Dedivitis RA; Ramos DM; Matos LL; Garcia MRT; Conti GG; Kowalski LP
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1627-1635. PubMed ID: 33095433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of pathologically determined tumour volume in glottic carcinomas treated by transoral laser microsurgery.
    Wilkie MD; Lightbody KA; Pinto R; Tandon S; Jones TM; Lancaster J
    Clin Otolaryngol; 2015 Dec; 40(6):610-5. PubMed ID: 25816841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of MRI-based late-course tumor volume in locoregionally advanced nasopharyngeal carcinoma.
    Yan G; Feng Y; Wu M; Li C; Wei Y; Hua L; Zhao G; Hu Z; Yao S; Hou L; Chen X; Liu Q; Huang Q
    Radiat Oncol; 2022 Jun; 17(1):111. PubMed ID: 35761414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy Versus Cordectomy in the Management of Early Glottic Cancer.
    Chung SY; Kim KH; Keum KC; Koh YW; Kim SH; Choi EC; Lee CG
    Cancer Res Treat; 2018 Jan; 50(1):156-163. PubMed ID: 28301924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of therapeutic effect and prognostic factors on early glottic carcinoma.
    Peng Z; Li Y; Jin L; Tao X; Cai X; Feng J; Liu R; Zhang Q; Li L
    Photodiagnosis Photodyn Ther; 2016 Sep; 15():167-71. PubMed ID: 27378675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic significance of CD105-assessed microvessel density in glottic laryngeal squamous cell carcinoma.
    Zvrko E; Mikic A; Vuckovic L
    Auris Nasus Larynx; 2010 Feb; 37(1):77-83. PubMed ID: 19553039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early glottic cancer involving the anterior commissure treated by transoral laser cordectomy.
    Hoffmann C; Cornu N; Hans S; Sadoughi B; Badoual C; Brasnu D
    Laryngoscope; 2016 Aug; 126(8):1817-22. PubMed ID: 26597482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcomes of supracricoid partial laryngectomy with cricohyoidoepiglottopexy for glottic carcinoma.
    Gong H; Zhou L; Wu H; Tao L; Chen X; Li X; Li C; Zhou J
    Acta Otolaryngol; 2019 Sep; 139(9):803-809. PubMed ID: 31240973
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of total tumor volume in advanced-stage laryngeal and hypopharyngeal carcinoma.
    Yang CJ; Kim DY; Lee JH; Roh JL; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2013 Dec; 108(8):509-15. PubMed ID: 24590673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx.
    Ko HC; Harari PM; Chen S; Wieland AM; Yu M; Baschnagel AM; Kimple RJ; Witek ME
    JAMA Otolaryngol Head Neck Surg; 2017 Nov; 143(11):1126-1133. PubMed ID: 29049434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.